openPR Logo
Press release

Transcranial Magnetic Stimulator (TMS) Market Global and Regional Outlook to 2027 - Neuronetics, TMS Neurosolutions, Mag Venture, eNeura, Neurosoft, REMED

11-14-2019 06:57 AM CET | Science & Education

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

The report covers key developments in the transcranial magnetic stimulator market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from transcranial magnetic stimulator market are anticipated to lucrative growth opportunities in the future with the rising demand for transcranial magnetic stimulator market in the global market. Below mentioned is the list of few companies engaged in the transcranial magnetic stimulator market.

Transcranial Magnetic Stimulator (TMS) Market to 2027 - Global Analysis and Forecasts By Type (Single or paired pulse TMS, Repetitive TMS (rTMS)); Age Group (Adults, Children); Application (Research, Diagnostic, Therapeutic), and Geography

Transcranial magnetic stimulation (TMS), also referred to us repetitive transcranial magnetic stimulation (rTMS), is a type of brain stimulation in which a changing magnetic field is applied to a specific area of the brain. An electric pulse stimulator, is attached to a magnetic coil, which is then connected to the scalp. It is a non-invasive procedure and is used for diagnostic and therapeutic applications.

Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00007242?utm_source=OpenPR&utm_medium=Simran

The "Global Transcranial Magnetic Stimulator Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of transcranial magnetic stimulator market with detailed market segmentation by type, age group, application and geography. The global transcranial magnetic stimulator market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading transcranial magnetic stimulator market players and offers key trends and opportunities in the market.

The global transcranial magnetic stimulator market is segmented on the basis of type, age group, and application. Based on type, the market is segmented as single or paired pulse TMS, repetitive TMS (rTMS). Based on age group, the market is segmented as adults and children. The application segment is further divided into research, diagnostic, and therapeutic.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global transcranial magnetic stimulator market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The transcranial magnetic stimulator market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Top Listed Companies are -
1. Brainsway Ltd.
2. Nexstim Plc
3. Magstim
4. Neuronetics Inc.
5. TMS Neurosolutions
6. Mag Venture
7. eNeura Inc
8. Neurosoft
9. REMED
10. MAG and More GmbH

The report analyzes factors affecting transcranial magnetic stimulator market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the transcranial magnetic stimulator market in these regions.

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00007242?utm_source=OpenPR&utm_medium=Simran

Contact us –
Phone : +1-646-491-9876
Email Id : sales@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transcranial Magnetic Stimulator (TMS) Market Global and Regional Outlook to 2027 - Neuronetics, TMS Neurosolutions, Mag Venture, eNeura, Neurosoft, REMED here

News-ID: 1867030 • Views:

More Releases from The Insight Partners

Green Building Materials Market Forecast 2031: Valued at US$ 791.93 Billion, Growing at 10.4% CAGR
Green Building Materials Market Forecast 2031: Valued at US$ 791.93 Billion, Gro …
The Green Building Materials Market size is expected to reach US$ 791.93 billion by 2031. The market is anticipated to register a CAGR of 10.4% during 2025-2031. Global Green Building Materials Market 2031 Report give our customers an exhaustive and top to bottom examination of Green Building Materials Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division,
Text Analytics Market Growth Forecast: Valued at US$ 29.53 Billion by 2031
Text Analytics Market Growth Forecast: Valued at US$ 29.53 Billion by 2031
The Text Analytics Market is evolving rapidly, fueled by breakthroughs in artificial intelligence, natural language processing, and the exploding volume of unstructured data from social media, customer feedback, and enterprise communications. Businesses worldwide are turning to text analytics solutions to unlock hidden insights, enhance customer experiences, and drive data-informed strategies. As organizations navigate complex data landscapes, text analytics stands out as a critical tool for competitive advantage. Download PDF: -https://www.theinsightpartners.com/sample/TIPTE100000198?utm_source=Openpr&utm_medium=10413 In today's
Genome Editing Market: Trends, Opportunities, and Future Outlook
Genome Editing Market: Trends, Opportunities, and Future Outlook
The genome editing market has emerged as one of the most dynamic and transformative sectors in biotechnology, driven by advancements in genetic engineering technologies and increasing applications across various fields. As of 2024, the market is witnessing significant growth, fueled by the rising demand for personalized medicine, agricultural innovations, and therapeutic solutions. This article explores the current trends, opportunities, and future outlook of the genome editing market. Get the sample request
Transdermal Drug Delivery System Market to Reach US$ 51,949.74 Million by 2030
Transdermal Drug Delivery System Market to Reach US$ 51,949.74 Million by 2030
The Transdermal Drug Delivery System Market is entering a new era of growth, driven by rising demand for non-invasive drug administration, patient-friendly therapies, and technological innovation. According to industry analysis, the market size is expected to grow from US$ 37,230.28 million in 2022 to US$ 51,949.74 million by 2030, recording a CAGR of 4.3% during 2022-2030. This trajectory highlights the increasing adoption of transdermal patches, gels, sprays, and other advanced

All 5 Releases


More Releases for TMS

Neuralia TMS Broadens Access to Non-Invasive TMS Treatment for Depression
Australia, 27th Jan 2026 - Neuralia TMS, a respected provider of non-invasive neuromodulation therapies, has announced an expansion of access to Transcranial Magnetic Stimulation treatment for individuals living with depression, reflecting continued developments in evidence-based mental health care and increasing demand for non-pharmacological treatment options. The expanded availability is intended to support patients seeking additional clinical pathways under medical supervision. Transcranial Magnetic Stimulation, commonly known as TMS, is a non-invasive procedure
Neuralia TMS Broadens Access to Non-Invasive TMS Treatment for Depression
Australia, 27th Jan 2026 - Neuralia TMS, a respected provider of non-invasive neuromodulation therapies, has announced an expansion of access to Transcranial Magnetic Stimulation treatment for individuals living with depression, reflecting continued developments in evidence-based mental health care and increasing demand for non-pharmacological treatment options. The expanded availability is intended to support patients seeking additional clinical pathways under medical supervision. Transcranial Magnetic Stimulation, commonly known as TMS, is a non-invasive procedure
Neuralia TMS Opens Doors in Melbourne to Meet Rising Demand for TMS Treatment Ac …
Australia, 17th Dec 2025 - Neuralia TMS, a leader in Transcranial Magnetic Stimulation (TMS) therapy, has officially opened a new clinic in Moonee Ponds to address the increasing demand for alternative treatments for mental health and chronic pain. The new facility offers non-invasive TMS therapy to treat conditions such as depression, anxiety, and chronic pain by using magnetic pulses to stimulate specific areas of the brain, providing patients with an
Neuralia TMS Provides Proven TMS Therapy to Help Manage Depression
Australia, 19th Nov 2025 - Neuralia TMS, a respected provider of neuromodulation treatments in Melbourne's inner north, has reaffirmed its commitment to delivering evidence-supported Transcranial Magnetic Stimulation (TMS) therapy for individuals experiencing treatment-resistant depression. The clinic, located at Suite 102/149-155 Pascoe Vale Rd, Moonee Ponds 3039 VIC, continues to operate as a treatment centre offering structured, non-invasive therapeutic programs grounded in current clinical research. TMS therapy has become an established component
TMS (Transcranial Magnetic Stimulation) Coil Market Analysis By Manufacturers - …
The TMS (Transcranial Magnetic Stimulation) Coil Market Research Report Forecasts 2019-2025 is a valuable source of insightful data for business strategists. This TMS (Transcranial Magnetic Stimulation) Coil Market study provides comprehensive data on aspects of competitive intelligence, market research, strategy, planning, pricing and forecasting that enhances the understanding, scope, and application of this report. According to this study, over the next five years, the TMS (Transcranial Magnetic Stimulation) Coil market will
TMS celebrates 50 not out
Dubai, 15th June 2016:- This is the 50th edition of the TMS Newsletter and The Maritime Standard would like to thank all its readers for their support in helping reach this significant milestone. Clive Woodbridge, editor, says, “We are very grateful for the encouragement and positive feedback that our readers have given us. It is our aim to continue to improve the newsletter and we look forward to expanding and enhancing